☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Suspension
Kala Pharmaceuticals' Eysuvis (loteprednol etabonate ophthalmic suspension) Receives US FDA's Approval for Dry Eye Disease
October 27, 2020
Mylan Launches MPA Injectable Suspension for Prevention of Pregnancy in the US
October 20, 2018
Load more...
Back to Home
Modal title
×
Modal body text goes here.
